attention deficit-hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: The intervention group will receive magnesium (magnesium sulfate tablet) at a dose of 6 milligram per day and vitamin D (pearl) at a dose of 50000 international unit per week. Interven
Treatment - Drugs
The intervention group will receive magnesium (magnesium sulfate tablet) at a dose of 6 milligram per day and vitamin D (pearl) at a dose of 50000 international unit per week
Control group will receive placebo.
Sponsors
Vice chancellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) age between 6-12 year 2) signing informed written consents to participate in the study 4) serum 25-OH-vitamin D level less than 30 ng/dl 5) serum Mg level less than 2.3 mg/dl. Exclusion criteria: 1) Ages outside the above range 2) Unwillingness to participate in the study 3) having chronic medical diseases 4) serum 25-OH-vitamin D level more than 30 ng/dl and serum Mg level more than 2.3 mg/dl.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive and behavioral function. Timepoint: before, 4 weeks and 8 weeks after intervention. Method of measurement: Conner's Parent Rating Scale (CPRS).;Cognitive and behavioral function. Timepoint: before, 4 weeks and 8 weeks after intervention. Method of measurement: Strength and Difficulties Questionnaire (SDQ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum vitamin D level. Timepoint: First and end of intervention(2 month). Method of measurement: ELISA.;Serum magnesium level. Timepoint: First and end of intervention(2 month). Method of measurement: spectrophotometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMostafa Hemamy
Isfahan University of Medical Sciences
Outcome results
None listed